[
  {
    "ts": "2026-02-05T05:44:26+00:00",
    "headline": "5 Insightful Analyst Questions From Thermo Fisher’s Q4 Earnings Call",
    "summary": "Thermo Fisher’s fourth quarter results exceeded Wall Street’s top-line and non-GAAP profit expectations, yet the market responded negatively, reflecting investor concerns beyond headline beats. Management highlighted robust growth in bioproduction, steady performance in clinical research, and continued momentum in pharma and biotech customer segments as key drivers. CEO Marc Casper attributed the quarter’s revenue strength to high-impact product launches—such as the Orbitrap Astro Zoom mass spec",
    "url": "https://finance.yahoo.com/news/5-insightful-analyst-questions-thermo-054426600.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "b98bc67b-e3f0-30b3-802d-a17996df2099",
      "content": {
        "id": "b98bc67b-e3f0-30b3-802d-a17996df2099",
        "contentType": "STORY",
        "title": "5 Insightful Analyst Questions From Thermo Fisher’s Q4 Earnings Call",
        "description": "",
        "summary": "Thermo Fisher’s fourth quarter results exceeded Wall Street’s top-line and non-GAAP profit expectations, yet the market responded negatively, reflecting investor concerns beyond headline beats. Management highlighted robust growth in bioproduction, steady performance in clinical research, and continued momentum in pharma and biotech customer segments as key drivers. CEO Marc Casper attributed the quarter’s revenue strength to high-impact product launches—such as the Orbitrap Astro Zoom mass spec",
        "pubDate": "2026-02-05T05:44:26Z",
        "displayTime": "2026-02-05T05:44:26Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/a737e16c66c2727c7cdfa5d8d212cbf8",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "TMO Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/h_vxe3gZWBX1D4Eo00T90w--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/a737e16c66c2727c7cdfa5d8d212cbf8.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tEsIdyecPiyLV_MS6Sygfg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/a737e16c66c2727c7cdfa5d8d212cbf8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/5-insightful-analyst-questions-thermo-054426600.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/5-insightful-analyst-questions-thermo-054426600.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TMO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T14:07:14+00:00",
    "headline": "IQVIA forecasts weak annual profit on higher interest expenses",
    "summary": "Healthcare data and clinical research provider IQVIA Holdings on Thursday forecast annual profit below Wall Street expectations, weighed ​down by higher interest costs, even as strong fourth-quarter results underscored ‌improving demand from pharmaceutical clients. The results come amid persistent challenges facing contract research and analytics ‌companies, as cautious biotech funding and longer decision cycles continue in some markets. The company expects 2026 adjusted earnings in the range of $12.55 to $12.85 per share, falling far short of analysts' average estimate of $12.95 per share, according to LSEG ⁠data.",
    "url": "https://finance.yahoo.com/news/iqvia-forecasts-weak-annual-profit-140714120.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "319083b9-bc6c-325d-9d7e-db626d355ebf",
      "content": {
        "id": "319083b9-bc6c-325d-9d7e-db626d355ebf",
        "contentType": "STORY",
        "title": "IQVIA forecasts weak annual profit on higher interest expenses",
        "description": "",
        "summary": "Healthcare data and clinical research provider IQVIA Holdings on Thursday forecast annual profit below Wall Street expectations, weighed ​down by higher interest costs, even as strong fourth-quarter results underscored ‌improving demand from pharmaceutical clients. The results come amid persistent challenges facing contract research and analytics ‌companies, as cautious biotech funding and longer decision cycles continue in some markets. The company expects 2026 adjusted earnings in the range of $12.55 to $12.85 per share, falling far short of analysts' average estimate of $12.95 per share, according to LSEG ⁠data.",
        "pubDate": "2026-02-05T14:07:14Z",
        "displayTime": "2026-02-05T14:07:14Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Reuters",
          "url": "http://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-forecasts-weak-annual-profit-140714120.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-forecasts-weak-annual-profit-140714120.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IQV"
            },
            {
              "symbol": "TMO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T14:00:00+00:00",
    "headline": "OpenAI Introduces an Enterprise Platform for AI Agents",
    "summary": "Pervasive artificial-intelligence co-workers will be a reality by year end, according to OpenAI.  It is called Frontier, which is a new platform to help companies build, deploy, and manage AI agents.  “Frontier gives AI coworkers the ability to reason over data and complete complex tasks, like working with files, running code, and using tools,” OpenAI said in the blog post.",
    "url": "https://www.barrons.com/articles/openai-ai-agent-builder-frontier-de420da3?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "18b1d09e-cabe-372d-adf6-1fcedbd5dff8",
      "content": {
        "id": "18b1d09e-cabe-372d-adf6-1fcedbd5dff8",
        "contentType": "STORY",
        "title": "OpenAI Introduces an Enterprise Platform for AI Agents",
        "description": "",
        "summary": "Pervasive artificial-intelligence co-workers will be a reality by year end, according to OpenAI.  It is called Frontier, which is a new platform to help companies build, deploy, and manage AI agents.  “Frontier gives AI coworkers the ability to reason over data and complete complex tasks, like working with files, running code, and using tools,” OpenAI said in the blog post.",
        "pubDate": "2026-02-05T14:00:00Z",
        "displayTime": "2026-02-05T14:00:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/18b1d09e-cabe-372d-adf6-1fcedbd5dff8/openai-introduces-an.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/dd7c0a9d84c9e9de7a154152aae418e9",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YNCHmaWWUU1HBbFHPCSYfg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/dd7c0a9d84c9e9de7a154152aae418e9.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/v3zG3GRRBfA_pW6lzZsTdA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/dd7c0a9d84c9e9de7a154152aae418e9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/openai-ai-agent-builder-frontier-de420da3?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "OPAI.PVT"
            },
            {
              "symbol": "TMO"
            },
            {
              "symbol": "UBER"
            },
            {
              "symbol": "INTU"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]